Code of Ethics
Don Avison is a lawyer and consultant with Avison and Associates in Victoria, British Columbia. Prior to returning to private practice, he had a long and distinguished career in the public sector. With the federal Department of Justice, he served in many roles including general counsel, regional director general and as the first director general responsible for the Aboriginal Justice Initiative. This was followed by an appointment as deputy minister of justice for the Northwest Territories. He then returned home to BC, where he held deputy minister appointments in Education, Advanced Education, Crown Corporations and Health. He left government in 1999 and spent the next 10 years providing leadership as the first president of the University Presidents’ Council (now the Research Universities Council) of BC. Don served on the Providence Health Care Board from 2010-2013 and joined the Board of the Centre for Drug Research and Development in February of 2014.
With nearly 20 years of senior management experience, including more than five years as the PHSA’s chief communications officer and nearly two years as PHSA’s VP Communications & Research Administration, Ellen Chesney brings a strong background in health care and strategic management to her role as chief administrative officer, research. Prior to joining the PHSA, Ms. Chesney was the director of public affairs and communications with Children’s & Women’s Health Centre of BC.
As chief administrative officer, research, Ms. Chesney works with our agencies to ensure we are maximizing opportunities for efficiencies and effectiveness in research administration. She also works to strengthen PHSA’s role as an academic partner in collaboration with key academic institutions.
Andrew Hazlewood is the former Assistant Deputy Minister of Population Health and Wellness for the British Columbia Ministry of Health Planning. Mr. Hazlewood began his career in Public Health in 1972 with the Saskatchewan Department of Health. In 1986, he joined the British Columbia Ministry of Health and has held increasingly responsible positions in the public and preventive health field. He was responsible for developing policy frameworks for all health prevention, promotion and protection programs, including specific strategic initiatives targeted towards Womens and Seniors health issues, Aboriginal Health, HIV/AIDS and Tobacco Issues. Mr. Hazlewood provided direction and leadership on all aspects of British Columbia’s tobacco reduction strategy.
Carmond Ng is an associate with PwC Vancouver providing assurance services for private and public companies within the insurance, technology and life sciences industries. He is currently enrolled in the CPA Professional Education Program (PEP) and has just earned his MPAcc at the Edwards School of Business (University of Saskatchewan). Prior to accountancy, he received his undergraduate Bachelor of Science degree in Behavioural Neuroscience from McMaster University and also worked at the British Columbia Centre for Excellence in HIV/AIDS as a clinical research assistant from 2009 to 2014. During his time here, Carmond conducted both research and clinical tests in molecular genetics for the benefit of patients with HIV or Hepatitis C.
Dr. Judith Hall, Professor Emerita in the Departments of Pediatrics and Medical Genetics, is a pediatrician and clinical geneticist who has worked on birth defects and non-traditional mechanisms of disease. She has published over 300 original articles, 140 chapters and sections of conference proceedings, and 10 books, 2 of which have received awards. She has conducted clinical research for the past 35 years with a major interest in the description of the natural history of genetic disorders, congenital anomalies, and arthrogryposis. She has served in many leadership roles, including Chair of the UBC and BC Children’s Hospital Departments of Pediatrics, the Western Society of Pediatrics, as well as on numerous national and international committees and boards. She has served as president of the American Society of Human Genetics and of the American Pediatric Society.
Dr. Hall is a Board member of Genome Canada, the Michael Smith Foundation for Health Research, the Vancouver Foundation, and the Canadian Institute of Academic Medicine. Dr. Hall has received Lifetime Achievement Awards from Wellesley College, the University of Washington Medical School, and the University of British Columbia Medical School. Dr. Hall was named one of America’s top 1,000 doctors by American Health magazine in 1996 and she became an Officer of the Order of Canada in 1998, Founding Fellow of the Canadian Academy of Health Sciences in 2005, and a Fellow of the Royal Society of Canada in 2011. On April 11, 2012, Dr. Hall received the Queen Elizabeth II Diamond Jubilee Medal. Dr. Hall was again recognized for her numerous contributions to health around the world in 2015, when she was inducted into the Canadian Medical Hall of Fame.
Cathy Daminato is recognized as an innovative, energetic and strategic executive with the ability to motivate and inspire extraordinary commitment and support in aid of health and education initiatives in Greater Vancouver. Over the past 28 years Cathy has held leadership roles at Douglas College, BCIT, the Royal Columbian Hospital Foundation
and Simon Fraser University.
In 2003, she became the first Vice-President of Advancement and Alumni Engagement at Simon Fraser University, tripling the fundraising activity, building endowments and raising significant funds for key capital projects. Most recently under Cathy’s leadership SFU launched and successfully completed its largest fundraising effort to date, the $250 million Power of Engagement 50th Anniversary Campaign, raising $275 million. Cathy’s leadership ability, authenticity, strategic thinking, marketing acumen and communications skills have been critical to her success. As a volunteer she led the creation of a new fundraising management certificate program at BCIT, and served on various boards and committees of the Association of Fundraising Professionals nationally and internationally, including a term as Chair of the Association of Fundraising Professionals Vancouver Chapter. She has also been a board member of the Canadian Council for the Advancement of Education, the SFU University Trust, President of the SFU Foundation and Friends of SFU Foundation, and a member of BC Pets and Friends.
Cathy was awarded the AFP’s Giving Hearts Lifetime Achievement Award in November 2014 and was a finalist for a Woman of Distinction Award in the Non-profit and Public Service category in 2007.
Cathy holds a B.Sc. (Life Sciences with Honours) from Queen’s University, and MBA from the University of British Columbia and an ICD.D designation by the Institute of Corporate Directors in Toronto, Ontario.
Kelly is a partner in Human Capital Strategies, a consulting firm specializing in workforce development. She is a senior executive with over 20 years’ experience leading not-for-profit organizations.
Prior to HCS, Kelly founded and led the Immigrant Employment Council of BC as its CEO. IEC-BC is the provincial employer-facing organization that achieves the integration of skilled immigrant talent into the province’s workforce.
Kelly brings more than 20 years of experience in developing strategic initiatives to attract and integrate internationally trained talent in BC. She is a sought-after speaker, and a thought-leader and subject matter expert on immigration.
Prior to IEC-BC, Kelly was the Director of Employment and Language Programs at MOSAIC, one of the largest immigrant serving organizations in Western Canada.
Born in the United Kingdom in 1943, Dr. Perry Kendall completed his undergraduate medical training at University College Hospital Medical School in 1968 and interned at the Seaman’s Hospital in Greenwich, before spending a year as Senior House Officer at the University Hospital of the West Indies in Kingston, Jamaica. In 1972, he moved to Toronto, Ontario and spent two years working in general practice and at Toronto’s Hassle Free Clinic.
In 1974, he moved to Vancouver and worked for the Vancouver Health Department’s Pine Free Clinic and East Health unit while acquiring a Master’s Degree in Health Care Planning and Epidemiology and a Fellowship in Community Medicine. In 1984, he returned to Ontario and was the Manager, Disease Control and Epidemiology Services with the Ontario Ministry of Health, until 1987. He then returned to BC as Medical Officer of Health for the Capital Regional District, in which capacity he opened one of Canada’s first needle exchange programs. In 1989 he took on the role of Medical Health Officer for the City of Toronto, a position he held for six years during which time he pioneered programs for AIDS/HIV and drug abuse prevention, established Harm Reduction as the official City policy for substance abuse and was involved in developing and promoting the City’s comprehensive tobacco control by-laws.
In 1993, Dr. Kendall spent a year on secondment to the Deputy Minister of Health as Special Advisor on Long Term Care and Population Health. In March 1995, he was appointed President and CEO of the Addiction Research Foundation of Ontario, one of six academic health science centres in Toronto and a WHO Collaborating Centre, a position he held until the Foundation’s amalgamation with three other hospitals to form the Addiction and Mental Health Services Corporation on January 23, 1998. In April 1998, he took on the position of Vice-President, Seniors’ Health, with the Capital Health Region in Victoria. May 3, 1999, Dr. Kendall was appointed to the position of Provincial Health Officer for the province of British Columbia. During his term as BC’s Provincial Health Officer, Dr. Kendall received a variety of awards and recognition. In particular he was awarded the Order of BC in June 2005, he received the Queen’s Diamond Jubilee Award in June 2013 and the BC Premier’s Legacy Award in October 2015.
Dr Kendall retired from public service in January 2018 and joined the Foundation board in March 2018.
Dr. Gardy is a Senior Scientist at the British Columbia Centre for Disease Control, responsible for the genomics/molecular epidemiology portfolio in Communicable Disease Prevention and Control Services. An Assistant Professor in SPPH since March, 2013, Dr. Gardy is also an Associate Member of UBC’s Department of Microbiology and Immunology in the Faculty of Science. She obtained her BSc in Cell Biology & Genetics from UBC in 2000 and completed her PhD at Simon Fraser University in 2006 under Dr. Fiona Brinkman, working on bacterial genomics and bioinformatics-based predictive methods. She completed three years of postdoctoral training in the R.E.W. Hancock laboratory at UBC, using systems biology techniques to study the mammalian innate immune response and working on visualization tools to facilitate scientists’ exploration of biological network data.
Dr. Gardy joined BCCDC in 2009, where she works in the emerging field of genomic epidemiology, combining whole genome sequencing with both new and old epidemiological techniques to understand the origins, evolution, and transmission dynamics of outbreak organisms, including tuberculosis. She also leads BCCDC’s Research Development Unit and is a member of several Research Advisory Councils, including the Women’s Health Research Institute, the Michael Smith Foundation for Health Research, and the Provincial Health Services Authority. Dr. Gardy is also a passionate science communicator involved in a number of science media projects, including regular appearances on CBC Television’s documentary series The Nature of Things and a recurring guest host role on Discovery Channel’s nightly science newsmagazine, Daily Planet. Her first children’s book, “It’s Catching: the Infectious World of Germs and Microbes” was published by Owlkids Books in 2014. As of October 2014, Dr Gardy is a Tier 2 Canada Research Chair in Public Health Genomics.
Dr. Mark Tyndall came to the BCCDC in September of 2014 to take the position as the Executive Medical Director. In addition, he was appointed to be a deputy Provincial Health Officer and the Director of the UBC Centre for Disease Control Research Institute. Prior to coming to Vancouver, he was the Chief of the Division of Infectious Diseases at the University of Ottawa and a Senior Scientist at the Ottawa Hospital Research Institute. Mark received his Medical degree from McMaster University, his infectious diseases fellowship training at the University of Manitoba and his doctoral degree in epidemiology from Harvard University. From 1999 to 2010 he was the Program Director for Epidemiology at the BC Centre for Excellence in HIV/AIDS. He has conducted numerous community-based research projects in Vancouver, including epidemiologic studies of HIV and Hepatitis C transmission, antiretroviral access among injection drug users, health care utilization among marginalized populations, and was the co-lead investigator for Vancouver’s supervised injection site. Mark has international research experience in a number of countries and resided in Kenya for 4 years as part of the WHO collaborative research group. He is an author on over 200 peer-reviewed publications, primarily around HIV prevention among people who use drugs.
Alan Winter served as President and CEO of Genome British Columbia, a not-for-profit research organization established in Vancouver to enable British Columbia to become a world leader in selected areas of genomics R&D and to develop a vibrant life sciences cluster in the province, from 2001 to 2016. Dr. Winter received his Ph.D. from Queen’s University, Kingston, and was recognized by the Queen’s alumni Legacy of Achievement. He has wide experience at senior levels in the technology industry and in government over the past 25 years. In 2007, Dr. Winter received a Leadership Award from LifeSciences BC. He is a Fellow of the Canadian Academy of Engineering and the American Association for the Advancement of Science (AAAS) and a Fellow of the Canadian Astronautics and Space Institute, from which he received their inaugural Alouette Award. Dr. Winter served as Chair of the BCCDC Foundation for Public Health Board from January 2008 until February 2015, and subsequently served as an Advisory Member to the Board for an additional year. The Board and staff appreciate the dedication to the Foundation through its early growth stages, which would not have been possible without Dr. Winter’s guidance and expertise.
Dr. Robert C. Brunham is the Head of the Vaccine Research Laboratory at the University of British Columbia Centre for Disease Control. Until 2014, he was the Executive and Scientific Director of the British Columbia Centre for Disease Control (BCCDC). Dr. Brunham is also a Professor of Medicine at UBC. He has over 350 publications and an h-index of 53, as calculated by ISI’s Web of Knowledge. He is internationally regarded as an expert on infectious diseases and well known for his research on Chlamydia, SARS and HIV.
In 2005 Dr. Brunham received the CIHR Partnership Award for exemplifying research excellence by bringing health research communities together. His belief in seeking fundamental understanding of scientific problems while maximizing their benefit to society has been characterized by a career of partnership across the broad breadth of medical biosciences including molecular biology, clinical investigation and public health studies.
In 2015, Dr Brunham was elected a Fellow of the Royal Society of Canada, which is the highest honour a scholar can achieve in the Arts, Humanities and Sciences.
In Chlamydia research, Dr. Brunham is a world authority. He has made seminal contributions to defining the clinical features of infection in women, evaluating the impact of screening and treatment control programs, determining the underlying mechanisms of immunity, and discovering protective antigens suitable for vaccine development. He has innovatively analyzed the impact of public health efforts to control Chlamydia, deduced that the strategy is arresting the development of immunity and concluded that a vaccine will be essential to success.
Dr. Brunham is also well known for his work in elucidating the SARS genome, defining the characteristic clinical features of SARS as a clinical entity and tracing its distinctive epidemiology to underlying network transmission dynamics. As well, Dr. Brunham’s contribution to understanding HIV is significant. He collaborated in determining the major role of chancroid in concentrating accelerated HIV transmission among high-risk groups in Africa and the major role of HLA molecules in HIV resistance and susceptibility.
Dr. Brunham has been integral in establishing and developing the BCCDC Foundation and has dedicated his expertise and time to the organization for ten years, providing direction, advice and invaluable support to the Board of Directors.
Kristy Kerr is the Executive Director of the BCCDC Foundation, where she is responsible for overall strategic and operational responsibilities, and the consistent achievement of the mission, growth and financial objectives of the BCCDC Foundation. Kristy manages day-to-day administrative functions, finance management , HR, fund development, communications, and research promotions, and most importantly, building the profile of the BCCDC and the BCCDC Foundation. Kristy initially joined BCCDC in a UBC research management role before her transition into Foundation management in 2013 and the UBC CDC and Foundation remain collaborative partners.
Kristy has a Masters in Public Health with a specialization in Health Promotion, as well as a Bachelor of Science in Animal Biology and an Associate of Arts Degree in Creative Writing. She has extensive experience in grant development and management, having spent six years as a Research Grant Development Officer for the UBC Faculty of Medicine. One of her passions is global health, specifically maternal, newborn and child health focusing on the community level and the social determinants of health. Kristy spends time working with Zambians on various community-based initiatives and is working on developing a new initiative in Kenya with a team of BCCDC researchers. Her interests include the use of health promotion strategies and principles to advocate for human rights, social justice, and health equity.
Kristy is Board Vice-President for McLaren Housing Society, a Vancouver-based non-profit organization that provides housing and support services to people living with HIV who have low/limited income, are inadequately housed or are at risk of homelessness. She is dedicated to this work, as well as other community development activities.
Join us: as partner, sponsor or collaborator, in the conduct of public health research that is cutting edge, relevant, builds capacity and leverages resources.
SUPPORTING THE BC CENTRE FOR DISEASE CONTROL
Copyright 2014. BCCDC Foundation. Charitable Reg #861277309RR0001
Photo credits: Michael Donoghue, Yin Chang and David Niddire